EE9800020A - Use of ipriflavone to reduce CD8 + cell counts - Google Patents

Use of ipriflavone to reduce CD8 + cell counts

Info

Publication number
EE9800020A
EE9800020A EE9800020A EE9800020A EE9800020A EE 9800020 A EE9800020 A EE 9800020A EE 9800020 A EE9800020 A EE 9800020A EE 9800020 A EE9800020 A EE 9800020A EE 9800020 A EE9800020 A EE 9800020A
Authority
EE
Estonia
Prior art keywords
ipriflavone
reduce
cell counts
counts
cell
Prior art date
Application number
EE9800020A
Other languages
Estonian (et)
Inventor
B. Kov�cs Attila
Ar�nyi P�ter
Kerepesi Ter�zia
V�rai Gy�rgy
Tar Attila
Original Assignee
Chinoin Gy�gyszer �s Vegy�szeti Term�kek Gy�ra Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gy�gyszer �s Vegy�szeti Term�kek Gy�ra Rt. filed Critical Chinoin Gy�gyszer �s Vegy�szeti Term�kek Gy�ra Rt.
Publication of EE9800020A publication Critical patent/EE9800020A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
EE9800020A 1995-07-21 1996-07-16 Use of ipriflavone to reduce CD8 + cell counts EE9800020A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9502198A HU9502198D0 (en) 1995-07-21 1995-07-21 Novel indication
PCT/HU1996/000038 WO1997003664A1 (en) 1995-07-21 1996-07-16 Use of ipriflavone to reduce the number of cd8+ cells

Publications (1)

Publication Number Publication Date
EE9800020A true EE9800020A (en) 1998-08-17

Family

ID=10987063

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800020A EE9800020A (en) 1995-07-21 1996-07-16 Use of ipriflavone to reduce CD8 + cell counts

Country Status (22)

Country Link
EP (1) EP0841915A1 (en)
JP (1) JP2001503371A (en)
KR (1) KR19990028933A (en)
CN (1) CN1191483A (en)
AR (1) AR002905A1 (en)
AU (1) AU6367096A (en)
BG (1) BG102182A (en)
BR (1) BR9610187A (en)
CA (1) CA2227421A1 (en)
CZ (1) CZ2798A3 (en)
EA (1) EA199800146A1 (en)
EE (1) EE9800020A (en)
HR (1) HRP960345A2 (en)
HU (1) HU9502198D0 (en)
IL (1) IL122751A0 (en)
MX (1) MX9800603A (en)
NO (1) NO980127D0 (en)
PL (1) PL324460A1 (en)
SK (1) SK3298A3 (en)
WO (1) WO1997003664A1 (en)
YU (1) YU42796A (en)
ZA (1) ZA966079B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241079B (en) * 1990-03-23 1993-12-29 Chiesi Farma Spa PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCEDURE FOR THEIR PREPARATION AND RELATED THERAPEUTIC USE
HU212932B (en) * 1993-08-02 1996-12-30 Chinoin Gyogyszer Es Vegyeszet Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition

Also Published As

Publication number Publication date
AR002905A1 (en) 1998-04-29
SK3298A3 (en) 1998-07-08
KR19990028933A (en) 1999-04-15
AU6367096A (en) 1997-02-18
EP0841915A1 (en) 1998-05-20
CZ2798A3 (en) 1998-06-17
CA2227421A1 (en) 1997-02-06
MX9800603A (en) 1998-04-30
BG102182A (en) 1998-08-31
IL122751A0 (en) 1998-08-16
NO980127L (en) 1998-01-12
JP2001503371A (en) 2001-03-13
HU9502198D0 (en) 1995-09-28
PL324460A1 (en) 1998-05-25
ZA966079B (en) 1998-01-19
EA199800146A1 (en) 1998-08-27
BR9610187A (en) 1998-07-28
YU42796A (en) 1999-03-04
WO1997003664A1 (en) 1997-02-06
NO980127D0 (en) 1998-01-12
HRP960345A2 (en) 1998-02-28
CN1191483A (en) 1998-08-26
WO1997003664A8 (en) 1999-08-05

Similar Documents

Publication Publication Date Title
FI980033A (en) Inhibitors of cell attachment
NO985160D0 (en) Use of interleukin-10 to prepare a population of suppressor cells
ITTO910156A1 (en) COMPOUND TO ENHANCE HUMAN PERFORMANCE
KR970001337A (en) How to increase melamine purity
EE9800020A (en) Use of ipriflavone to reduce CD8 + cell counts
GB9225819D0 (en) Improvements relating to buildings
FI950264A (en) Improvements to small breads
IT8747747A0 (en) IMPROVEMENTS TO THE CONSTRUCTION OF SINGLE-FAMILY HOUSING BUILDINGS
DK0744399T3 (en) Conversion of substituted 8-chloroquinolines to substituted 8-hydroxyquinolines
KR970004663A (en) How to predict the usable time by type of battery
KR970027978U (en) Structure of slide hammer
NO960187D0 (en) Use of alkyl polyglycosides to reduce friction
KR950017206U (en) How to make concrete trough
KR970015857U (en) How to put bakery impurities
KR940021214A (en) How to convert foamed EVA waste into fireproof material
KR940002728U (en) Pack of affix attached to clothing
SE8402593D0 (en) OVERVOLTAGE PROTECTION OF SMALL COMPUTER HOUSES
SE8404414D0 (en) OVERVOLTAGE PROTECTION OF SMALL COMPUTER HOUSES
GB2305445B (en) Improvements relating to buildings
KR960036089U (en) Easy to fix dial structure
KR970047086U (en) Structure of battery
KR970006552U (en) Ondol structure of building
BR9500859A (en) Case to pack small jewels
KR970021213U (en) Assembly structure of the flash attached to the pocket tool
GB9013388D0 (en) Improvements relating to roofs of buildings